相关实验视频
Updated: Jun 13, 2025

05:39
Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice
Published on: December 27, 2024
343
医疗保健支出与中枢神经系统癌症的死亡率:有没有变化?
Eddie Guo1,2,3, Mehul Gupta3, Heather Rossong1,3
1Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
Neuro-oncology practice
|September 16, 2024
概括
对中枢神经系统 (CNS) 癌症的医疗保健支出大幅增加,但死亡率也上升. 这表明,中枢神经系统癌症患者的成本上升和改善的生存结果之间存在脱节.
科学领域:
- 在瘤学瘤学.
- 卫生经济学 卫生经济学
- 公共卫生 公共卫生
背景情况:
- 中枢神经系统 (CNS) 癌症对医疗保健系统,纳税人和患者造成了巨大的经济负担.
- 与中枢神经系统癌症相关的直接,间接和无形成本是显著的.
- 以前的研究还没有完全阐明医疗保健支出与中枢神经系统癌症存活率之间的关系.
研究的目的:
- 调查医疗保健支出趋势对美国中枢神经系统癌症存活率的影响.
- 分析对中枢神经系统癌症治疗的金融投资与患者死亡率结果之间的关系.
- 鉴定中枢神经系统癌症医疗保健支出变化的关键驱动因素.
主要方法:
- 利用了来自2016年疾病支出项目和2019年全球疾病负担研究的公共数据.
- 分析了从1996年到2016年对中枢神经系统瘤的年度医疗保健支出趋势,以流行率,发病率和死亡率进行调整.
- 根据年龄,支出类型和护理类型进行了子组分析.
主要成果:
- 对中枢神经系统癌症的医疗保健总支出从1996年的272亿美元上升到2016年的685亿美元.
- 尽管增加了支出,但每10万人的死亡率从1996年的5.30增加到2016年的7.02.
- 45-64岁的患者,拥有私人保险的患者和接受住院护理的患者的支出最高.
结论:
- 中枢神经系统癌症医疗保健成本的显著增加并没有导致死亡率相应下降.
- 医疗保健支出不断增加,医学进步和中枢神经系统癌症患者生存结果之间似乎存在不匹配.
- 需要进行进一步的研究,以优化资源配置,改善中枢神经系统癌症护理患者的治疗结果.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Psychoneuroimmunology: Diabetes and Cancer
26
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
26
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K

